Zacks Research Has Negative Outlook for Hologic Q3 Earnings
Hologic, Inc. (NASDAQ:HOLX – Free Report) – Investment analysts at Zacks Research cut their Q3 2025 EPS estimates for Hologic in a report issued on Wednesday, May 21st. Zacks Research analyst R. Department now forecasts that the medical equipment provider will post earnings per share of $1.05 for the quarter, down from their prior estimate […]
